Showing 13 posts of 13 posts found.


Gilead’s Truvada becomes first China-approved drug to prevent HIV-1

August 13, 2020
Sales and Marketing China, Truvada, approval. HIV

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …


Gilead challenges Government over patents on preventative HIV drug Truvada

August 22, 2019
Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents

Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …


Gilead CEO Daniel O’Day challenged over patents on PrEP drug Truvada

May 17, 2019
Medical Communications Gilead, HIV, PrEP, Truvada, patent, pharma

On 16 May, Gilead CEO Daniel O’Day was grilled over the $1,780 price tag on PrEP drug Truvada in a …


Gilead will give 11 years’ worth of PrEP drugs to those at risk of HIV after ‘discussions’ with Trump

May 10, 2019
Medical Communications Gilead, HIV, PrEP, Trump, Truvada, descovy

Gilead Sciences has agreed to donate 11 years’ worth PrEP drugs for up to 200,000 individuals each year, following “discussions …

Gilead accused of ripping off US taxpayers

March 28, 2019
Medical Communications, Sales and Marketing CDC, Gilead, HIV, PrEP, Truvada, US government, patents

Gilead have been accused of ‘ripping off’ US taxpayers after the firm was revealed to have generated $3 billion in …


AIDS charity lambasts “ethically challenged” Gilead over price hikes

January 11, 2018
Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical

The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …

Anti-HIV drug PrEP proves safety in gay and bisexual adolescents

September 6, 2017
Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma

A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …

HIV-preventing drug to be trialed across England

August 7, 2017
Medical Communications, Sales and Marketing NHS, NHS England, PrEP, Truvada, biotech, drugs, pharma, pharmaceutical

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …


Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …


Gilead gets EU approval for HIV-prevention treatment Truvada

August 23, 2016
Manufacturing and Production, Sales and Marketing EU, Gilead, HIV, PrEP, Truvada, prevention

Gilead Sciences has received marketing authorisation from the European Commission for once-daily Truvada (emtricitabine/tenofovir disoproxil), in combination with safer sex …

Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015
Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

Latest content